Market Cap 212.99M
Revenue (ttm) 1.08B
Net Income (ttm) 95.40M
EPS (ttm) N/A
PE Ratio 1.32
Forward PE 2.13
Profit Margin 8.83%
Debt to Equity Ratio -2.12
Volume 1,071,700
Avg Vol 2,034,648
Day's Range N/A - N/A
Shares Out 59.33M
Stochastic %K 92%
Beta 0.83
Analysts Hold
Price Target $4.00

Company Profile

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headqu...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 862 401 0000
Address:
300 Kimball Drive, Suite 300, Parsippany, United States
LordWorld
LordWorld Jul. 30 at 2:59 PM
$EMBC BUY ✅ Average share price: $3.27
0 · Reply
LordWorld
LordWorld Jul. 29 at 8:06 PM
$EMBC I also expect a meaningful reduction in the free float. As CEOKurdikar previously stated, Embecta planned to begin its $100M share repurchase program in Q2, with approximately $33MALLOCATED per year over three years. My view is that the strongest buying opportunity came after the May 5 selloff, when the stock collapstoward $3.00 but consistently refused to break lower despite heavy selling pressure. The same pattern appeared during the forced selling around the S&P Sc 600 deletion on Jun 18 and Jun 22, when extraordinary volume hit the market, yet the $3AREA continued to absorb supply. Based on that price action, I believe Embc may have already retired roughly 3–5 mil shares, potentially reducing the effective float from about 59 mil shares to approximately 54–56 mil. If upcoming earnings confirm meaningful buyback activity, new customer wins, and continued business execution, the combination of a smaller float and improving fundamentals could create a very powerful move higher.
1 · Reply
TradingThyme
TradingThyme Jul. 29 at 4:57 PM
$EMBC Look for some significant catalysts these coming weeks! Beat EPS estimates by 7-12 cents through the reduction of dividends. Earnings call announcing significant new contracts signed with a definitive path forward. Solidify and start the stock repurchase in the upcoming quarter. It has been a boring slow ride but diamond hands will prevail!
0 · Reply
LordWorld
LordWorld Jul. 29 at 8:24 AM
$EMBC https://lnkd.in/p/d43ByhhX
0 · Reply
DDtrader444
DDtrader444 Jul. 28 at 5:51 PM
$EMBC I’m ready to hear they did part of the buyback with this tiny free float..👀↗️
0 · Reply
TradingThyme
TradingThyme Jul. 28 at 3:08 PM
0 · Reply
LordWorld
LordWorld Jul. 28 at 1:58 PM
$EMBC The market is experiencing a shortage of shares due to a continuous decline in the free float.
1 · Reply
Stockpooper30
Stockpooper30 Jul. 26 at 4:54 PM
$EMBC can embecta turn around ???!
0 · Reply
Stockpooper30
Stockpooper30 Jul. 26 at 1:14 AM
$EMBC guys what do you think the earnings going to be
1 · Reply
LordWorld
LordWorld Jul. 25 at 9:37 AM
$EMBC https://www.linkedin.com/posts/owenmumford_healthcareprofessionals-medicaltechnology-activity-7485984637266284544-Sjzh?utm_source=share&utm_medium=member_ios&rcm=ACoAAF8uyZsBJ4KgRdzHO0a-goDvvWzFA3Mt4oA
0 · Reply
Latest News on EMBC
embecta to Report Fiscal Third Quarter Financial Results

Jul 23, 2026, 5:00 PM EDT - 7 days ago

embecta to Report Fiscal Third Quarter Financial Results


embecta to Participate in Investor Events

Jun 1, 2026, 5:00 PM EDT - 2 months ago

embecta to Participate in Investor Events


Embecta price target lowered to $3 from $11 at BofA

2026-05-18T12:09:46.000Z - 2 months ago

Embecta price target lowered to $3 from $11 at BofA


embecta Completes Acquisition of Owen Mumford Holdings Limited

May 15, 2026, 9:00 AM EDT - 2 months ago

embecta Completes Acquisition of Owen Mumford Holdings Limited


Embecta price target lowered to $5 from $12 at Mizuho

2026-05-07T06:57:11.000Z - 3 months ago

Embecta price target lowered to $5 from $12 at Mizuho


Embecta Earnings Call Transcript: Q2 2026

May 5, 2026, 8:00 AM EDT - 3 months ago

Embecta Earnings Call Transcript: Q2 2026


Embecta Earnings release: Q2 2026

May 5, 2026, 8:00 AM EDT - 3 months ago

Embecta Earnings release: Q2 2026


Embecta Slides: Q2 2026

May 5, 2026, 8:00 AM EDT - 3 months ago

Embecta Slides: Q2 2026


Embecta Quarterly report: Q2 2026

May 5, 2026, 8:00 AM EDT - 3 months ago

Embecta Quarterly report: Q2 2026


Embecta reports Q2 adjusted EPS 27c, consensus 42c

2026-05-05T10:48:58.000Z - 3 months ago

Embecta reports Q2 adjusted EPS 27c, consensus 42c


embecta Announces Quarterly Cash Dividend

May 5, 2026, 6:30 AM EDT - 3 months ago

embecta Announces Quarterly Cash Dividend


Embecta management to meet virtually with BTIG

2026-04-29T17:50:52.000Z - 3 months ago

Embecta management to meet virtually with BTIG


embecta to Report Fiscal Second Quarter Financial Results

Apr 21, 2026, 5:00 PM EDT - 3 months ago

embecta to Report Fiscal Second Quarter Financial Results


Embecta price target lowered to $12 from $14 at Mizuho

2026-04-13T14:41:50.000Z - 3 months ago

Embecta price target lowered to $12 from $14 at Mizuho


Embecta price target lowered to $22 from $25 at BTIG

2026-04-13T11:55:26.000Z - 3 months ago

Embecta price target lowered to $22 from $25 at BTIG


Embecta acquiring Owen Mumford Holdings

2026-03-19T10:46:35.000Z - 4 months ago

Embecta acquiring Owen Mumford Holdings


Embecta elects CEO Devdatt Kurdikar as chairman

2026-02-11T21:21:38.000Z - 6 months ago

Embecta elects CEO Devdatt Kurdikar as chairman


Embecta Earnings Call Transcript: Q1 2026

Feb 5, 2026, 8:00 AM EST - 6 months ago

Embecta Earnings Call Transcript: Q1 2026


Embecta Quarterly report: Q1 2026

Feb 5, 2026, 8:00 AM EST - 6 months ago

Embecta Quarterly report: Q1 2026


Embecta Earnings release: Q1 2026

Feb 5, 2026, 8:00 AM EST - 6 months ago

Embecta Earnings release: Q1 2026


Embecta Slides: Q1 2026

Feb 5, 2026, 8:00 AM EST - 6 months ago

Embecta Slides: Q1 2026


Embecta reports Q1 adjusted EPS 71c, consensus 67c

2026-02-05T11:42:06.000Z - 6 months ago

Embecta reports Q1 adjusted EPS 71c, consensus 67c


Embecta Proxy statement: Proxy Filing

Jan 23, 2026, 7:00 AM EST - 6 months ago

Embecta Proxy statement: Proxy Filing


embecta to Report Fiscal First Quarter Financial Results

Jan 22, 2026, 5:00 PM EST - 6 months ago

embecta to Report Fiscal First Quarter Financial Results


Embecta Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 5:15 PM EST - 7 months ago

Embecta Slides: 44th Annual J.P. Morgan Healthcare Conference


Embecta Proxy statement: Proxy Filing

Dec 18, 2025, 7:00 AM EST - 8 months ago

Embecta Proxy statement: Proxy Filing


Embecta Proxy statement: Proxy Filing

Dec 18, 2025, 7:00 AM EST - 8 months ago

Embecta Proxy statement: Proxy Filing


Embecta Earnings Call Transcript: Q4 2025

Nov 25, 2025, 8:00 AM EST - 8 months ago

Embecta Earnings Call Transcript: Q4 2025


Embecta Annual report: Q4 2025

Nov 25, 2025, 8:00 AM EST - 8 months ago

Embecta Annual report: Q4 2025


Embecta Earnings release: Q4 2025

Nov 25, 2025, 8:00 AM EST - 8 months ago

Embecta Earnings release: Q4 2025


Embecta Slides: Q4 2025

Nov 25, 2025, 8:00 AM EST - 8 months ago

Embecta Slides: Q4 2025


Embecta reports Q4 adjusted EPS 50c, consensus 46c

2025-11-25T11:35:52.000Z - 8 months ago

Embecta reports Q4 adjusted EPS 50c, consensus 46c


Embecta sees FY26 adjusted EPS $2.80-$3.00, consensus $2.95

2025-11-25T11:35:41.000Z - 8 months ago

Embecta sees FY26 adjusted EPS $2.80-$3.00, consensus $2.95


embecta announces changes to Board of Directors

Nov 17, 2025, 5:00 PM EST - 9 months ago

embecta announces changes to Board of Directors


Embecta management to meet with BTIG

2025-09-09T14:20:26.000Z - 11 months ago

Embecta management to meet with BTIG


Embecta price target lowered to $11 from $18 at BofA

2025-08-08T18:45:13.000Z - 1 year ago

Embecta price target lowered to $11 from $18 at BofA


Embecta Earnings Call Transcript: Q3 2025

Aug 8, 2025, 8:00 AM EDT - 1 year ago

Embecta Earnings Call Transcript: Q3 2025


Embecta Quarterly report: Q3 2025

Aug 8, 2025, 8:00 AM EDT - 1 year ago

Embecta Quarterly report: Q3 2025


Embecta Earnings release: Q3 2025

Aug 8, 2025, 8:00 AM EDT - 1 year ago

Embecta Earnings release: Q3 2025


Embecta Slides: Q3 2025

Aug 8, 2025, 8:00 AM EDT - 1 year ago

Embecta Slides: Q3 2025


Embecta reports Q3 adjusted EPS $1.12 vs. 74c last year

2025-08-08T10:35:32.000Z - 1 year ago

Embecta reports Q3 adjusted EPS $1.12 vs. 74c last year


embecta to Report Fiscal Third Quarter 2025 Financial Results

Jul 24, 2025, 5:00 PM EDT - 1 year ago

embecta to Report Fiscal Third Quarter 2025 Financial Results


Embecta price target lowered to $12 from $13 at Mizuho

2025-07-16T11:42:06.000Z - 1 year ago

Embecta price target lowered to $12 from $13 at Mizuho


Embecta Transcript: Investor Day 2025

May 22, 2025, 9:00 AM EDT - 1 year ago

Embecta Transcript: Investor Day 2025


Embecta Slides: FY 2025

May 22, 2025, 9:00 AM EDT - 1 year ago

Embecta Slides: FY 2025


Embecta Earnings Call Transcript: Q2 2025

May 9, 2025, 8:00 AM EDT - 1 year ago

Embecta Earnings Call Transcript: Q2 2025


Embecta Quarterly report: Q2 2025

May 9, 2025, 8:00 AM EDT - 1 year ago

Embecta Quarterly report: Q2 2025


Embecta Earnings release: Q2 2025

May 9, 2025, 8:00 AM EDT - 1 year ago

Embecta Earnings release: Q2 2025


Embecta Slides: Q2 2025

May 9, 2025, 8:00 AM EDT - 1 year ago

Embecta Slides: Q2 2025


Embecta to host Analyst and Investor Day on May 22, 2025

Apr 28, 2025, 7:30 AM EDT - 1 year ago

Embecta to host Analyst and Investor Day on May 22, 2025


LordWorld
LordWorld Jul. 30 at 2:59 PM
$EMBC BUY ✅ Average share price: $3.27
0 · Reply
LordWorld
LordWorld Jul. 29 at 8:06 PM
$EMBC I also expect a meaningful reduction in the free float. As CEOKurdikar previously stated, Embecta planned to begin its $100M share repurchase program in Q2, with approximately $33MALLOCATED per year over three years. My view is that the strongest buying opportunity came after the May 5 selloff, when the stock collapstoward $3.00 but consistently refused to break lower despite heavy selling pressure. The same pattern appeared during the forced selling around the S&P Sc 600 deletion on Jun 18 and Jun 22, when extraordinary volume hit the market, yet the $3AREA continued to absorb supply. Based on that price action, I believe Embc may have already retired roughly 3–5 mil shares, potentially reducing the effective float from about 59 mil shares to approximately 54–56 mil. If upcoming earnings confirm meaningful buyback activity, new customer wins, and continued business execution, the combination of a smaller float and improving fundamentals could create a very powerful move higher.
1 · Reply
TradingThyme
TradingThyme Jul. 29 at 4:57 PM
$EMBC Look for some significant catalysts these coming weeks! Beat EPS estimates by 7-12 cents through the reduction of dividends. Earnings call announcing significant new contracts signed with a definitive path forward. Solidify and start the stock repurchase in the upcoming quarter. It has been a boring slow ride but diamond hands will prevail!
0 · Reply
LordWorld
LordWorld Jul. 29 at 8:24 AM
$EMBC https://lnkd.in/p/d43ByhhX
0 · Reply
DDtrader444
DDtrader444 Jul. 28 at 5:51 PM
$EMBC I’m ready to hear they did part of the buyback with this tiny free float..👀↗️
0 · Reply
TradingThyme
TradingThyme Jul. 28 at 3:08 PM
0 · Reply
LordWorld
LordWorld Jul. 28 at 1:58 PM
$EMBC The market is experiencing a shortage of shares due to a continuous decline in the free float.
1 · Reply
Stockpooper30
Stockpooper30 Jul. 26 at 4:54 PM
$EMBC can embecta turn around ???!
0 · Reply
Stockpooper30
Stockpooper30 Jul. 26 at 1:14 AM
$EMBC guys what do you think the earnings going to be
1 · Reply
LordWorld
LordWorld Jul. 25 at 9:37 AM
$EMBC https://www.linkedin.com/posts/owenmumford_healthcareprofessionals-medicaltechnology-activity-7485984637266284544-Sjzh?utm_source=share&utm_medium=member_ios&rcm=ACoAAF8uyZsBJ4KgRdzHO0a-goDvvWzFA3Mt4oA
0 · Reply
LordWorld
LordWorld Jul. 24 at 1:28 PM
0 · Reply
ExploringTrades
ExploringTrades Jul. 23 at 11:05 PM
0 · Reply
LordWorld
LordWorld Jul. 21 at 10:07 PM
$EMBC https://www.linkedin.com/posts/autoinjectors-market-to-worth-usd-30046-share-7485224840837226496-FRCW/?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAAF8uyZsBJ4KgRdzHO0a-goDvvWzFA3Mt4oA&utm_campaign=share_via
0 · Reply
DDtrader444
DDtrader444 Jul. 21 at 2:16 PM
$EMBC will soon touch and stay even higher👌⬆️⬆️⬆️↗️
0 · Reply
Miansohaibb
Miansohaibb Jul. 21 at 11:13 AM
$EMBC just touched 3.95$.
0 · Reply
ajmrtxl
ajmrtxl Jul. 17 at 4:53 PM
0 · Reply
LordWorld
LordWorld Jul. 16 at 7:46 PM
$EMBC embecta - Nimish Muzumdar https://lnkd.in/p/dKkKf6NX
0 · Reply
David676767
David676767 Jul. 16 at 3:11 PM
0 · Reply
DragonOfBosnia
DragonOfBosnia Jul. 16 at 2:57 PM
$EMBC This is insanely cheap. PE under 2 $ABT
0 · Reply
DragonOfBosnia
DragonOfBosnia Jul. 16 at 2:47 PM
$BSX $MDT $ABT medical devices getting some love.. check out $EMBC beat the f up...
0 · Reply
DDtrader444
DDtrader444 Jul. 16 at 12:18 AM
$EMBC people are going to be shocked when they realize they should have listened to the fact that this is way oversold and way undervalued 🤷‍♂️
0 · Reply